339 related articles for article (PubMed ID: 8079186)
1. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Davies MG; Huynh TT; Hagen PO
J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
[TBL] [Abstract][Full Text] [Related]
3. Control of accelerated vein graft atheroma with the nitric oxide precursor: L-arginine.
Davies MG; Dalen H; Kim JH; Barber L; Svendsen E; Hagen PO
J Surg Res; 1995 Jul; 59(1):35-42. PubMed ID: 7630134
[TBL] [Abstract][Full Text] [Related]
4. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
5. Celiprolol reduces the intimal thickening of autogenous vein grafts via an enhancement of nitric oxide function through an inhibition of superoxide production.
Hattori K; Yamanouchi D; Banno H; Kobayashi M; Yamamoto K; Kajikuri J; Itoh T; Komori K
J Vasc Surg; 2007 Jul; 46(1):116-23. PubMed ID: 17606127
[TBL] [Abstract][Full Text] [Related]
6. Constitutive nitric oxide synthase is expressed and nitric oxide-mediated relaxation is preserved in retrieved human aortocoronary vein grafts.
Davies MG; Berkowitz DE; Hagen PO
J Surg Res; 1995 Jun; 58(6):732-8. PubMed ID: 7540701
[TBL] [Abstract][Full Text] [Related]
7. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
8. Functional and histological differences in autogenous and allogenic vein grafts: two different vasculopathies?
Davies MG; Dalen H; Svendsen E; Hagen PO
J Surg Res; 1997 Apr; 69(1):14-22. PubMed ID: 9202641
[TBL] [Abstract][Full Text] [Related]
9. L-arginine polymers inhibit the development of vein graft neointimal hyperplasia.
Kown MH; Yamaguchi A; Jahncke CL; Miniati D; Murata S; Grunenfelder J; Koransky ML; Rothbard JB; Robbins RC
J Thorac Cardiovasc Surg; 2001 May; 121(5):971-80. PubMed ID: 11326242
[TBL] [Abstract][Full Text] [Related]
10. Hypercholesterolemia and experimental vein grafts: accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function.
Klyachkin ML; Davies MG; Svendsen E; Kim JH; Massey MF; Barber L; McCann RL; Hagen PO
J Surg Res; 1993 May; 54(5):451-68. PubMed ID: 8361171
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe reduces intimal hyperplasia in rabbit jugular vein graft.
Maekawa T; Komori K; Morisaki K; Itoh T
J Vasc Surg; 2012 Dec; 56(6):1689-97. PubMed ID: 22857809
[TBL] [Abstract][Full Text] [Related]
12. Sarpogrelate hydrochloride reduced intimal hyperplasia in experimental rabbit vein graft.
Kodama A; Komori K; Hattori K; Yamanouchi D; Kajikuri J; Itoh T
J Vasc Surg; 2009 May; 49(5):1272-81. PubMed ID: 19233592
[TBL] [Abstract][Full Text] [Related]
13. The nitric oxide precursor L-arginine reduces expression of hyaluronan synthase in experimental vein bypass grafts.
Dattilo JB; Dattilo MP; Crane JT; Yager DR; Makhoul RG
J Surg Res; 1998 Jan; 74(1):39-42. PubMed ID: 9536971
[TBL] [Abstract][Full Text] [Related]
14. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.
Kodama A; Komori K; Kajikuri J; Itoh T
J Vasc Surg; 2009 Sep; 50(3):617-25. PubMed ID: 19700096
[TBL] [Abstract][Full Text] [Related]
16. Regression of intimal hyperplasia with restoration of endothelium-dependent relaxing factor-mediated relaxation in experimental vein grafts.
Davies MG; Klyachkin ML; Dalen H; Svendsen E; Hagen PO
Surgery; 1993 Aug; 114(2):258-70; discussion 270-1. PubMed ID: 8342130
[TBL] [Abstract][Full Text] [Related]
17. The temporal sequence of G-protein expression in intimal hyperplasia.
Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
[TBL] [Abstract][Full Text] [Related]
18. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
19. Topical mitogen-activated protein kinases inhibition reduces intimal hyperplasia in arterialized vein grafts.
Gulkarov I; Bohmann K; Cinnante KM; Pirelli L; Yu PJ; Grau JB; Pintucci G; Galloway AC; Mignatti P
J Surg Res; 2009 Jun; 154(1):150-6. PubMed ID: 18805551
[TBL] [Abstract][Full Text] [Related]
20. Postprocedure administration of insulin in canine autologous vein grafting: a potential strategy to attenuate intimal hyperplasia.
Zhou N; Yu QJ; Si R; Gao HK; Wang T; Gao F; Wang HC; Bian JF
J Cardiovasc Pharmacol; 2010 Oct; 56(4):402-12. PubMed ID: 20625311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
